University & Program

National Taiwan University

Pathology (Master's Degree)


Program Level
Master
Language of instruction
Taught in Chinese
Admission
Fall / Spring

The Department of Pathology at National Taiwan University (NTU) Hospital traces its origins back to the Classroom of Pathology at Taihoku (Taipei) Imperial University in the 1930s, eventually evolving into the Department of Pathology, College of Medicine, NTU after World War II. The Graduate Institute of Pathology was established in 1947, marking a significant expansion in teaching and research capabilities. By 1954, the department relocated to NTU Hospital, where it merged into a specialized unit offering comprehensive services in surgical pathology, cytology, and anatomical pathology. Over the years, the department has been at the forefront of pathology education and research in Taiwan, particularly focusing on the pathogenesis, molecular pathology, and diagnosis of prevalent diseases in the region. The Ph.D. program was introduced in 1969, further enhancing its academic and research contributions. Subsequent developments included the separation of the Department of Forensic Medicine in 1984 and the division of master’s and doctoral programs into medical and para-medical graduate groups in 1989.

The Department of Pathology continues to play a pivotal role in medical education, offering undergraduate students foundational knowledge in pathology and providing internship programs for medical and medical technology students to familiarize them with pathological specimen processing. At the graduate level, the institute aims to train researchers and educators capable of integrating basic and clinical techniques to advance the study of diseases prevalent in Taiwan. Courses emphasize pathology experiments, molecular biology, cellular biology, and experimental pathology, equipping students with essential skills in disease research and critical analysis. The department is renowned for its research excellence in areas such as lung cancer, hepatoma, nasopharyngeal carcinoma, and malignant lymphoma, leveraging advanced tools like next-generation sequencing and proteomics to explore disease etiology, tumor biology, drug resistance mechanisms, and the development of diagnostic biomarkers and therapeutic strategies.



Websitehttps://www.mc.ntu.edu.tw/path/Index.action?l=en_US

Contact information


Office of International Affairs
Back to results